Metabolic activity of primary tumor on pet/ct has a relationship with survival in stage I ‐III small‐cell lung carcinoma

ConclusionPre ‐treatment SUVmax‐PT (median cut‐off 11.6) may have a prognostic value of OS and PFS in patients with TNM staged I‐III SCLC.

Source: The Clinical Respiratory Journal - March 16, 2020 Category: Respiratory Medicine Authors: Özer Özdemir, Özgür Batum, Sinem Ermin, Nimet Aksel, Berna Kömürcüoğlu, Aydan Mertoğlu, Sami Deniz, Günseli Balci, Hakan Koparal, Engin Özbilek, Ufuk Yilmaz Tags: ORIGINAL ARTICLE Source Type: research